- Home
- LGND vs CENX Comparison
LGND vs CENX Comparison
Compare LGND & CENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGND
- CENX
- Stock Information
- Founded
- LGND 1987
- CENX 1995
- Country
- LGND United States
- CENX United States
- Employees
- LGND N/A
- CENX N/A
- Industry
- LGND Biotechnology: Pharmaceutical Preparations
- CENX Aluminum
- Sector
- LGND Health Care
- CENX Industrials
- Exchange
- LGND Nasdaq
- CENX Nasdaq
- Market Cap
- LGND 2.0B
- CENX 1.7B
- IPO Year
- LGND 1992
- CENX 1996
- Fundamental
- Price
- LGND $124.30
- CENX $20.03
- Analyst Decision
- LGND Strong Buy
- CENX Strong Buy
- Analyst Count
- LGND 8
- CENX 3
- Target Price
- LGND $144.71
- CENX $23.00
- AVG Volume (30 Days)
- LGND 139.7K
- CENX 1.4M
- Earning Date
- LGND 08-05-2025
- CENX 08-07-2025
- Dividend Yield
- LGND N/A
- CENX N/A
- EPS Growth
- LGND N/A
- CENX N/A
- EPS
- LGND N/A
- CENX 1.22
- Revenue
- LGND $181,488,000.00
- CENX $2,364,700,000.00
- Revenue This Year
- LGND $18.41
- CENX $7.19
- Revenue Next Year
- LGND $18.87
- CENX $3.99
- P/E Ratio
- LGND N/A
- CENX $16.64
- Revenue Growth
- LGND 53.40
- CENX 11.41
- 52 Week Low
- LGND $81.74
- CENX $11.40
- 52 Week High
- LGND $129.90
- CENX $25.39
- Technical
- Relative Strength Index (RSI)
- LGND 64.68
- CENX 63.54
- Support Level
- LGND $120.68
- CENX $18.00
- Resistance Level
- LGND $127.07
- CENX $20.88
- Average True Range (ATR)
- LGND 3.76
- CENX 0.84
- MACD
- LGND 0.86
- CENX 0.21
- Stochastic Oscillator
- LGND 81.95
- CENX 81.66
About LGND Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.
About CENX Century Aluminum Company
Century Aluminum Co produces primary aluminum standard grade and value-added products. The firm operates smelter facilities in the United States and Iceland. The majority of revenue is generated from Glencore, which agreed to purchase nearly all of Century Aluminum's North American production. Century purchases nearly all of its alumina from Glencore. The company produces high purity aluminum, standard-grade aluminum sow and tee bars, and value-added billet and foundry products. Century also owns a carbon anode production facility in the Netherlands.